Filter announcements
Loading...
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.
Remus Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
Remus Pharmaceuticals has fixed Tuesday, September 22, 2026, as the record date for determining shareholder eligibility to receive a final dividend of Rs. 0.50 per equity share (face value Rs. 10 each) for the financial year 2025-26. If approved at the upcoming AGM, the payout will be distributed within 30...
Remus Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026
Remus Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
Remus Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot